by Michael Cannon, CATO Institute
From the Washington Post:
Hedge fund executives and other investors are increasingly interested in the timing and nature of health-policy decisions in Washington because they directly affect the profits and stock prices of pharmaceutical, insurance, hospital and managed-care companies…
[Former Centers for Medicare & Medicaid Services] director Thomas Scully, who served during the Bush administration…said he thought that it was useful for CMS officials to have more communication with Wall Street investors as a way for regulators to learn and “explain what an $800-billion-a-year agency” does with its money.
So long as someone is still making a buck, it’s not socialized medicine…right?
Latest posts by TAC Daily Updates (see all)
- Colorado House Votes to Bar State Agents from Assisting Federal Police - April 28, 2017
- Tenth Amendment Center Responds to White House Press Secretary’s Comments About Federal Marijuana Enforcement - February 23, 2017
- Promised ‘New Foreign Policy’ Must Abandon Regime Change for Iran - December 5, 2016